1-5 of 5
Anne-Marie Martin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials

Ademi Santiago-Walker, Robert Gagnon, Jolly Mazumdar, Michelle Casey, Georgina V. Long, Dirk Schadendorf, Keith Flaherty, Richard Kefford, Axel Hauschild, Patrick Hwu, Patricia Haney, Anne O'Hagan, Jennifer Carver, Vicki Goodman, Jeffrey Legos, Anne-Marie Martin
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (3): 567–574.
https://doi.org/10.1158/1078-0432.CCR-15-0321
Published: 31 January 2016
View article titled, Correlation of <em>BRAF</em> Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
Open the PDF for Correlation of <em>BRAF</em> Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials in another window
Includes: Supplementary data
Journal Articles

Predicting Clinical Activity to Lapatinib: Beyond ErbB2 (Her2)

Anne-Marie Martin
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): PL03-01.
Published: 15 August 2014
View article titled, Predicting Clinical Activity to Lapatinib: Beyond ErbB2 (Her2)
Journal Articles

Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer

Richard S. Finn, Michael F. Press, Judy Dering, Lisa O'Rourke, Allison Florance, Catherine Ellis, Anne-Marie Martin, Stephen Johnston
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (3): 736–743.
https://doi.org/10.1158/1078-0432.CCR-13-1260
Published: 02 February 2014
View article titled, Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Open the PDF for Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)

Katherine L. Nathanson, Anne-Marie Martin, Bradley Wubbenhorst, Joel Greshock, Richard Letrero, Kurt D'Andrea, Steven O'Day, Jeffrey R. Infante, Gerald S. Falchook, Hendrik-Tobias Arkenau, Michael Millward, Michael P. Brown, Anna Pavlick, Michael A. Davies, Bo Ma, Robert Gagnon, Martin Curtis, Peter F. Lebowitz, Richard Kefford, Georgina V. Long
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4868–4878.
https://doi.org/10.1158/1078-0432.CCR-13-0827
Published: 02 September 2013
View article titled, Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)
Open the PDF for Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436) in another window
Includes: Supplementary data
Journal Articles

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer

Michael F. Press, Richard S. Finn, David Cameron, Angelo Di Leo, Charles E. Geyer, Ivonne E. Villalobos, Angela Santiago, Roberta Guzman, Armen Gasparyan, Yanling Ma, Kathy Danenberg, Anne Marie Martin, Lisa Williams, Cristina Oliva, Steven Stein, Robert Gagnon, Michael Arbushites, Maria T. Koehler
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7861–7870.
https://doi.org/10.1158/1078-0432.CCR-08-1056
Published: 01 December 2008
View article titled, HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
Open the PDF for HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer in another window
Includes: Supplementary data